Vise Technologies’s Puma Biotechnology PBYI Stock Holding History

Vise Technologies’s Portfolio PBYI Stock Details PBYI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$240K	Hold	40,298	–	–	﹤0.01%	1281
2025 Q4	$240K	Buy	+40,298	New	+$214K	﹤0.01%	1291

Other funds holding PBYI

ACA

Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Vise Technologies's PBYI Position: Q1 2026 in Review

Vise Technologies held its Puma Biotechnology (PBYI) position steady in Q1 2026 at 40,298 shares worth $240K. The position accounts for ﹤0.01% of the portfolio, ranked #1281.

Vise Technologies first reported a position in PBYI in Q4 2025 and has held it in 2 quarters since. 157 funds tracked by Wall St. Rank hold PBYI as of Q1 2026.

Vise Technologies held 40,298 shares of Puma Biotechnology worth $240K as of Q1 2026.
Vise Technologies left its Puma Biotechnology share count unchanged in Q1 2026.
Puma Biotechnology made up ﹤0.01% of Vise Technologies's portfolio in Q1 2026, its #1281 holding.
Vise Technologies first reported a position in Puma Biotechnology in Q4 2025 and has held it in 2 quarters since.
157 funds tracked by Wall St. Rank held Puma Biotechnology as of Q1 2026.

Based on Vise Technologies's 13F filing for Q1 2026, filed 21 Apr 2026.